# Treatment Resistant Epilepsy and N-Acetyl Cysteine

> **NCT02054949** · NA · WITHDRAWN · sponsor: **Nationwide Children's Hospital**

## Conditions studied

- Autistic Disorder
- Seizures
- Irritability

## Interventions

- **DRUG:** N-Acetyl Cysteine (NAC)

## Key facts

- **NCT ID:** NCT02054949
- **Lead sponsor:** Nationwide Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-04
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** no eligible subjects located
- **Last updated:** 2015-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02054949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02054949, "Treatment Resistant Epilepsy and N-Acetyl Cysteine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02054949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*